NCT03855462View on ClinicalTrials.gov

Evaluating Medium-chain Triglycerides as a Temporary Intraocular Tamponading Agent for Retinal Detachment

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 17, 2018

Primary Completion Date

January 25, 2023

Study Completion Date

January 25, 2023

Conditions
Ophthalmopathy
Interventions
DEVICE

MCT oil injection

"The patient treatment is the classical surgical procedure which is used for retinal detachment with MCT oil :~* Vitrectomy, then flattened retina, and finally MCT injection in place of the vitreous.~* MCT ablation after 4 to 6 weeks (after effective retinopexy)~* after MCT ablation, total follow-up duration by patient is 6 months."

Trial Locations (2)

31059

University Hospital Toulouse (Hospital Pierre Paul Riquet), Toulouse

Unknown

Polyclinique Saint Roch, Montpellier

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER

NCT03855462 - Evaluating Medium-chain Triglycerides as a Temporary Intraocular Tamponading Agent for Retinal Detachment | Biotech Hunter | Biotech Hunter